The returns from innovation in medical technology will decrease, affecting inventive firms throughout the world that rely on the American market to recoup their research costs.

• 医疗科技创新的回报率将大大降低，这对于那些依靠美国市场获得研究经费的创新型公司来说无疑是具有打击性的。